Hospital finance has moved beyond the familiar cycle of annual budgeting and episodic cost containment. In 2025, Kaufman Hall reported an adjusted year-to-date operating margin of 1.3% across its national hospital sample, even as patient demand, bad debt, and expense intensity remained volatile (1). The American Hospital Association (AHA), using industry benchmark data, estimated that total hospital expenses grew 7.5% in 2025, including 5.6% growth in workforce costs, 9.9% in supplies, and 13.6% in drugs; these are industry-sponsored estimates and should be interpreted alongside independent payment and market evidence (2). MedPAC’s 2026 assessment likewise described deeply negative fee-for-service Medicare margins while evaluating payment adequacy, access, cost growth, and quality together rather than treating any one margin measure as dispositive (3).

Aggregate results conceal substantial variation. Hospital profitability is associated with size, system affiliation, teaching status, payer mix, costs, and local bargaining conditions (4). Commercial hospital prices also vary widely within and across markets, and market structure is strongly associated with negotiated prices (5). Conversely, higher commercial revenue does not necessarily produce leaner operations; evidence suggests that hospitals with greater private-payer revenue can tolerate higher cost structures, which may worsen measured Medicare margins (6). Financial resilience therefore cannot be reduced to either “payment is inadequate” or “costs are excessive.” Both claims may be true in different services, facilities, and time horizons.

The executive problem is to preserve the hospital’s capacity to meet clinical and community obligations through shocks while improving the value produced by every dollar. That requires attention to avoidable waste—estimated across the US health system in categories such as administrative complexity, pricing failure, overtreatment, and failures of care delivery—without assuming that all apparent variation is safely removable (7). It also requires explicit protection for access-sensitive organizations. Among financially distressed rural hospitals, community unemployment and uninsurance have been associated with closure risk, demonstrating that the balance sheet is inseparable from local socioeconomic conditions (8).

This review addresses two questions: which management disciplines most plausibly strengthen hospital financial resilience, and which policy levers can support rather than undermine those disciplines? It focuses on US acute-care hospitals while recognizing that ownership, geography, specialty mix, and payer environment materially affect the answer. We present this article in accordance with the narrative review reporting checklist.

This narrative review used a targeted, iterative search intended to support executive synthesis rather than estimate a pooled causal effect. The search was completed on August 12, 2026. PubMed/MEDLINE and Crossref were used to identify peer-reviewed research. Publicly available sources from CMS, MedPAC, RAND, AHA, Kaufman Hall, and the University of North Carolina Cecil G. Sheps Center were searched for current payment, cost, pricing, and rural-access information. Reference lists of eligible studies were examined for additional foundational works.

Search concepts combined terms for hospitals with financial performance, operating margin, liquidity, cost accounting, service lines, workforce, commercial prices, market concentration, value-based payment, rural closure, and revenue cycle. English-language publications from January 2010 through August 2026 were eligible; older sources were retained when they established a still-relevant costing or strategy method. Peer-reviewed empirical studies, systematic reviews, federal reports and rules, and transparent national datasets were prioritized. Commentaries were used sparingly to frame governance issues. Vendor or trade-association reports were included only when they provided timely national operating data unavailable from peer-reviewed sources and are identified as such.

Items were excluded when they concerned only insurer solvency, non-hospital settings without transferable implications, purely technical accounting rules, promotional claims without methods, or financial products unrelated to care delivery. Selection was performed by the author through title/summary screening followed by full-text or full-record review. Findings were organized into an enterprise resilience framework covering measurement, operating model, revenue integrity, capital, partnerships, and policy. Because this is a narrative review, no formal risk-of-bias score or meta-analysis was performed.

The completed search approach is summarized in Table 1.

The completed evidence-synthesis exhibits are presented in Supplementary Table S1.

Resilience is the capacity to absorb a shock, continue essential work, adapt the operating model, and restore strategic investment. It differs from a high margin. A hospital may post a favorable total margin because of investment income while its clinical operations consume cash. Another may post a low margin while carrying strong liquidity and an efficient cost structure. A third may be profitable only because high commercial prices cross-subsidize structurally negative service lines. The board therefore needs a layered view of performance: operating margin, days cash on hand, debt-service coverage, capital age, payer concentration, denial exposure, labor productivity, quality, access, and the contribution of mission-critical services.

The practical unit of management is not the general ledger alone. It is the clinical operating system that converts labor, capacity, supplies, and information into outcomes. Time-driven activity-based costing (TDABC) can reveal where resources are actually consumed across a care pathway; a systematic review found that TDABC was applicable in health care but also noted inconsistent methods and limited evidence that it alone improves bundled-payment performance (9). Accordingly, granular costing should be paired with outcome, demand, and equity measures. Cutting a high-cost step that prevents a complication is false economy; redesigning an idle handoff or duplicate authorization may release real capacity.

Resilience also requires a multi-horizon view. The first horizon is liquidity and operational continuity over days to months. The second is structural performance over one to three years: service portfolio, workforce model, throughput, payer contracts, and care migration. The third is renewal over three to ten years: facilities, digital infrastructure, clinical program investment, and community health. Decisions that improve one horizon can weaken another. Freezing maintenance protects near-term cash but increases downtime and replacement risk. Filling every vacancy with premium contract labor protects today’s schedule but can destabilize the employed workforce. A resilient plan states these transfers explicitly.

4.1 Establish one margin-and-mission dashboard

Hospitals commonly maintain separate finance, quality, workforce, access, and strategy dashboards. That fragmentation allows improvement in one domain to obscure harm in another. The board should receive a common set of leading and lagging measures, stratified where material by service line, site, payer, and patient population. Financial measures should include operating cash flow, normalized operating margin, days cash, denial aging, cost per adjusted encounter, and capital reinvestment. Operating measures should include staffed-bed availability, length of stay, discharge delays, procedure-room utilization, overtime, agency hours, and avoidable cancellations. Clinical and access guardrails should include harm, mortality, readmission, wait time, left-without-being-seen, workforce safety, and closure or restriction of essential services.

Targets should be expressed as ranges with escalation thresholds rather than a single annual number. A margin below plan caused by a deliberate, time-limited capacity investment is different from deterioration caused by uncontrolled premium labor or failed collections. A dashboard should make that distinction visible. It should also show the “cost of readiness”: the expense of maintaining emergency, obstetric, behavioral-health, trauma, infectious-disease, and other capabilities that cannot be staffed only when demand appears.

4.2 Manage care pathways, not departmental silos

Traditional departmental budgets encourage local optimization. Nursing can reduce hours while the emergency department boards patients; imaging can maximize utilization while discharges wait for tests; finance can reduce inventory while clinicians experience shortages. A care-pathway view identifies the constraint that governs flow and the total cost of resolution. The objective is not maximum utilization of every resource but reliable movement through the system at clinically appropriate speed.

Executives can begin with a limited set of high-volume or high-variance pathways. For each, the team should map demand, capacity, handoffs, rework, avoidable days, complications, supplies, professional effort, and postacute dependencies. The economic case should include released capacity and avoided future cost, not only line-item reductions. If a redesign shortens stay without creating unsafe discharge or greater readmission, its value may be realized as deferred bed expansion, additional appropriate admissions, or reduced staffing volatility rather than an immediate budget cut.

4.3 Treat workforce design as a financial strategy

Labor is both the largest expense category and the mechanism through which quality is delivered. An undifferentiated vacancy freeze can increase overtime, turnover, agency use, delays, and adverse outcomes. Workforce strategy should instead align skill, workload, schedule, and technology. This includes demand-based staffing, internal resource pools, cross-training, predictable scheduling, reduction of low-value documentation, team-based practice, and stronger manager capability.

Every workforce initiative should specify its theory of value. Automation may remove keystrokes but add exception handling. Centralization may reduce duplication but lengthen response time. A new role may add cost but prevent turnover or release a scarce clinician for higher-value work. The financial model should include recruitment, orientation, turnover, premium labor, productivity ramp, and quality effects. The board should require workforce changes to meet the same investment discipline applied to equipment.

4.4 Build revenue integrity without transferring burden to patients

Revenue-cycle performance is often treated as a back-office function, yet it affects access, clinician time, patient trust, and cash conversion. A resilient approach begins upstream: accurate coverage and identity data, clinically coherent documentation, transparent authorization ownership, charge capture, clean claims, and rapid denial learning. Denials should be categorized by root cause, payer, service, and preventability. The highest-value work is elimination of recurring defects, not expansion of a permanent appeals workforce.

CMS’s Interoperability and Prior Authorization Final Rule establishes decision timeframes, denial reasons, metrics, and application programming interface requirements for affected payers, with operational provisions beginning in 2026 and major API requirements generally in 2027 (10). Hospitals should use the transition to redesign authorization workflows around structured data and exception management. Automation should not simply accelerate a defective process. Measures should include touches per authorization, avoidable clinical peer-to-peer reviews, overturn rate, days delayed, and patient abandonment.

Patient financial processes require equal attention. Eligibility, estimates, financial assistance, payment plans, and collection should be designed as one service. Financial resilience gained through confusing estimates or aggressive collection is unstable: it increases complaints, bad debt, and reputational risk. Price-transparency files are also operational data assets. CMS began enforcing revised 2026 hospital price-transparency requirements on April 1, 2026, including more standardized allowed-amount information and attestation requirements (11). Hospitals can use the same governance needed for compliance to improve contract modeling and patient estimates.

5.1 Evaluate service lines through mission, market, and operating lenses

Service-line decisions should not be based on contribution margin alone. An emergency department may enable downstream care and fulfill a nondelegable community obligation. Obstetrics may be financially weak but indispensable to regional access. Conversely, a profitable service may depend on unsustainable prices, fragile referral patterns, or scarce staff. A portfolio review should score each service on clinical need, access, quality, strategic differentiation, direct and avoidable cost, downstream effects, capital needs, workforce feasibility, payer exposure, and availability of alternatives.

That framework supports four distinct decisions: strengthen, redesign, partner, or exit with a responsible transition. “Redesign” may include moving clinically appropriate work to ambulatory or home settings, standardizing supplies, consolidating low-volume hours, or integrating virtual expertise. “Partner” may preserve access through shared staffing, telehealth, mobile services, purchasing, laboratory, or back-office arrangements. Exit should be a last, governed choice with explicit patient and community mitigation.

Rural hospitals require special attention because low volume and geographic necessity challenge conventional scale economics. The federal Rural Emergency Hospital designation permits eligible facilities to discontinue inpatient care while maintaining emergency and outpatient services with specific Medicare support (12). It can be appropriate for some communities but is not a universal answer; leaders must assess transport, weather, referral capacity, workforce, and the clinical consequences of losing local inpatient capability. National closure tracking by the UNC Sheps Center is an important contextual source, but local scenario testing remains essential (13).

5.2 Allocate capital under scenarios, not forecasts alone

Capital plans often assume a single volume, payer, and inflation trajectory. Resilience requires scenarios: base, adverse, severe but plausible, and opportunity. Each should model revenue, labor, supply, interest, days cash, covenant headroom, and the ability to continue priority projects. Projects should be staged with decision gates, not merely ranked once each year.

The portfolio must include “unseen” capital: cybersecurity, power, water, air handling, clinical engineering, interoperability, and data quality. These investments may have weak conventional returns until a disruption occurs. Boards can evaluate them using expected-loss avoidance, continuity requirements, and risk appetite. Deferred maintenance should appear as a quantified liability, not as a favorable variance.

Partnerships and acquisitions should be subjected to the same discipline. Consolidation can create clinical scale and access but also increases integration cost and may increase commercial prices. Empirical evidence links hospital market power with higher negotiated prices (5), and early warnings about continuing hospital consolidation remain relevant (14). A transaction thesis should specify which capabilities, costs, quality outcomes, and access measures will improve; who owns integration; when benefits should appear; and what would trigger corrective action.

Table 2 translates these disciplines into a balanced executive operating system.

6.1 Predictability matters as much as rate level

Hospitals cannot redesign multi-year operations around repeated short-term policy extensions or rules finalized after capital and staffing decisions are made. Payment adequacy should be evaluated using access, quality, cost efficiency, and beneficiary outcomes, consistent with MedPAC’s approach (3). Updates should recognize efficient input-cost change and the fixed cost of readiness while preserving pressure to improve productivity. Temporary relief without structural expectations can perpetuate inefficient cost; abrupt reductions can force access cuts before redesign is possible.

Payment models should also reduce conflicting incentives. Fee-for-service rewards billable volume, while global budgets and accountable-care arrangements create incentives to prevent avoidable utilization and manage total cost. Evidence from Medicare accountable care organizations indicates that savings have varied by program maturity and organizational type, reinforcing that contracts do not substitute for operating capability (15). Models need sufficient duration, reliable attribution, risk adjustment, transparent benchmarks, and access safeguards. Hospitals need to know whether released bed capacity will reduce revenue, enable growth, or be recognized as value.

6.2 Site-neutrality requires clinical and access nuance

Paying different amounts for clinically similar services solely because of ownership or site can encourage acquisition and migration to higher-paid settings. More site-neutral payment can reduce distortions, but a blunt policy may ignore standby capacity, teaching, safety-net functions, or geographic necessity. The appropriate design separates the resource cost of the service from legitimate facility and readiness obligations. Transition support should be targeted to access risk rather than provided indefinitely to every hospital.

Commercial price policy presents a parallel challenge. RAND’s employer-led hospital price studies have documented large variation in prices paid by private plans relative to Medicare (16). Transparency can make that variation visible, but data alone do not create competitive alternatives in concentrated markets. Antitrust enforcement, contract rules, benefit design, and independent access monitoring are complementary levers. Policymakers should avoid assuming that lower negotiated prices automatically translate into lower patient premiums or that every high price represents equivalent market power; case mix, teaching, and regional access still require examination.

6.3 Administrative simplification is a financial and clinical policy

Administrative complexity consumes cash and clinician capacity. The CMS prior-authorization rule is a material step, but effective implementation depends on common data definitions, auditable denial reasons, and enforcement (10). National transaction data suggest that automation avoids substantial administrative expense while leaving a sizable remaining opportunity (17). The policy goal should be straight-through processing for predictable cases, rapid human review for clinical exceptions, and usable reporting on denials and delays.

Quality programs also require harmonization. Measurement that is clinically important but duplicative across payers creates non-value-added work. A smaller common core of validated measures, supplemented by targeted local measures, would support comparison and reduce extraction burden. Payment should reward outcome improvement without encouraging avoidance of high-risk patients.

6.4 Protect access during transformation

The closure of a financially weak service may improve an individual hospital’s statement while increasing ambulance time, uncompensated transfer burden, or mortality risk elsewhere. Policy therefore needs regional—not only facility-level—impact assessment. Tools include rural emergency-hospital support, global or prospective budgets, telehealth and transport infrastructure, shared workforce programs, and time-limited transformation funding tied to milestones.

Medicaid expansion has been associated with improvements in hospital financial performance and reductions in uncompensated care in multiple analyses; one early national study found improved hospital margins in expansion states relative to nonexpansion states (18). Coverage policy is thus also hospital resilience policy. However, coverage without adequate networks, timely payment, and manageable administration may not fully protect access.

Table 3 links the principal policy levers to their design safeguards.

A 24-month program can proceed in four overlapping waves. In the first 90 days, leaders establish governance, normalize margin and cash measures, identify access guardrails, map the largest sources of variance, and create an integrated benefits ledger. This is not a search for an arbitrary savings number. It is a shared factual baseline.

From months three through nine, teams redesign two to four priority pathways, strengthen cash and denial operations, stabilize premium labor, and apply scenario gates to capital. Benefits should be independently validated by finance and operations. “Savings” that merely shift expense to another department, defer needed work, or assume unfilled clinical demand should be rejected.

From months six through eighteen, the organization addresses the portfolio: service lines, ambulatory and home substitution, partnerships, payer contracts, and digital infrastructure. Clinical leaders must co-own decisions. The transformation office should be small and temporary; capabilities should migrate into line management rather than become a parallel bureaucracy.

From months twelve through twenty-four, the board tests durability. Are improvements maintained through seasonal volume, leadership turnover, a payer dispute, or a supply shock? Did quality or access deteriorate for any group? Were capital and workforce investments restored? Resilience is demonstrated when the operating system learns and adapts, not when a one-time target is reported.

7.1 Institutionalize shock readiness and benefits realization

The organization should convert the program from a temporary savings effort into routine management. The COVID-19 volume shock demonstrated how quickly the loss of elective and outpatient revenue can threaten hospital liquidity, particularly for smaller, independent, rural, and critical-access organizations (19). A standing resilience playbook should therefore define cash triggers, command authority, service-continuity priorities, labor redeployment, payer communication, and capital gates before a disruption occurs. Exercises should include a cyber outage, supply interruption, sharp volume loss, payer failure, and loss of a critical workforce group.

Scale should not be assumed to create savings. A national study of roughly 4,000 hospitals found no general evidence that system membership produced lower operating costs, although structure and centralization mattered (20). Shared services need named customers, service levels, unit costs, and an exit or redesign mechanism. Otherwise, centralization can conceal expense and reduce local responsiveness.

Benefits realization should remain linked to patient value—health outcomes achieved relative to resources used—rather than to cost alone (21). CMS’s Hospital Value-Based Purchasing and Hospital Readmissions Reduction programs illustrate how quality, efficiency, and payment interact at the facility level (22,23). Evidence relating readmission rates to financial performance also shows that the direction and timing of revenue and expense effects can be complex (24). A credible benefits ledger therefore separates cash savings, avoided future cost, released capacity, revenue improvement, and quality benefit; assigns an owner; and states when each should appear.

Finally, partnerships and transactions should be reviewed after close, not only before approval. The 2023 Merger Guidelines describe current federal enforcement frameworks for assessing competition (25). Hospital boards need an additional internal test: whether promised clinical integration, access, cost, and quality improvements occurred. Unmet transaction assumptions should trigger corrective action rather than disappear into goodwill.

This review integrates current federal payment information, national operating data, and peer-reviewed evidence into a board-level framework. It distinguishes margin, liquidity, readiness, and value; makes trade-offs explicit; and connects management actions with policy design. The completed search strategy and supplementary search details improve transparency.

The review is narrative rather than systematic. It did not search subscription-only management databases or perform duplicate screening, formal quality scoring, or meta-analysis. Timely operating estimates from industry organizations may reflect member or vendor samples and should not be treated as nationally representative without qualification. Financial performance is highly context dependent, and evidence from one ownership type or market may not transfer to another. Several recommended governance practices are reasoned applications of the evidence rather than interventions tested in randomized trials. Policy rules and payment levels can change after the search date.

Persistent hospital margin pressure cannot be solved by rate advocacy or expense reduction alone. Durable resilience comes from an operating system that connects cash, clinical pathways, workforce, revenue integrity, capital, quality, and community access. Boards should require transparent assumptions, scenario ranges, accountable benefit owners, and patient and workforce guardrails. Leaders should favor redesign that removes delay, rework, avoidable harm, and low-value variation over reductions that simply ration capacity.

Public policy should make efficient transformation possible: predictable payment, administratively simpler rules, appropriately designed site neutrality, competitive markets, and explicit protection for essential readiness and regional access. The central discipline is to distinguish cost that creates reliable clinical capacity from cost that reflects fragmentation. Hospitals that can make that distinction—and act on it before liquidity becomes the only priority—will be better positioned to sustain both mission and margin.